GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood–brain barrier

Every organ in the body requires blood vessels for efficient delivery of oxygen and nutrients, but independent vascular beds are highly specialized to meet the individual needs of specific organs. The vasculature of the brain is tightly sealed, with blood–brain barrier (BBB) properties developing coincident with neural vascularization. G protein-coupled receptor 124 (GPR124) (tumor endothelial marker 5, TEM5), an orphan member of the adhesion family of G protein-coupled receptors, was previously identified on the basis of its overexpression in tumor vasculature. Here, we show that global deletion or endothelial-specific deletion of GPR124 in mice results in embryonic lethality associated with abnormal angiogenesis of the forebrain and spinal cord. Expression of GPR124 was found to be required for invasion and migration of blood vessels into neuroepithelium, establishment of BBB properties, and expansion of the cerebral cortex. Thus, GPR124 is an important regulator of neurovasculature development and a potential drug target for cerebrovascular diseases.

[1]  K. Kinzler,et al.  Genes expressed in human tumor endothelium. , 2000, Science.

[2]  D. Ferriero,et al.  Role of vasodilator stimulated phosphoprotein in VEGF induced blood–brain barrier permeability in endothelial cell monolayers , 2010, International Journal of Developmental Neuroscience.

[3]  Sally Temple,et al.  Endothelial Cells Stimulate Self-Renewal and Expand Neurogenesis of Neural Stem Cells , 2004, Science.

[4]  Napoleone Ferrara,et al.  Angiogenesis as a therapeutic target , 2005, Nature.

[5]  T. Chaly,et al.  Induction of focal angiogenesis through adenoviral vector mediated vascular endothelial cell growth factor gene transfer in the mature mouse brain , 2004, Angiogenesis.

[6]  G. Breier,et al.  Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. , 1992, Development.

[7]  S. Seaman,et al.  Genes that distinguish physiological and pathological angiogenesis. , 2007, Cancer cell.

[8]  Holger Gerhardt,et al.  Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. , 2002, Genes & development.

[9]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[10]  H. Hammes,et al.  Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor , 2004, Thrombosis and Haemostasis.

[11]  M. Fowler,et al.  Congenital Hydrocephalus‐Hydrencephaly in Five Siblings, with Autopsy Studies: a New Disease , 1972, Developmental medicine and child neurology.

[12]  R. Hynes,et al.  Defective Associations between Blood Vessels and Brain Parenchyma Lead to Cerebral Hemorrhage in Mice Lacking αv Integrins , 2002, Molecular and Cellular Biology.

[13]  K. Walter,et al.  Plasmalemmal Vesicle Associated Protein-1 ( PV-1 ) is a marker of blood-brain barrier disruption in rodent models , 2008 .

[14]  K. Kinzler,et al.  Cell surface tumor endothelial markers are conserved in mice and humans. , 2001, Cancer research.

[15]  H. Bauer,et al.  Ontogenic expression of the erythroid-type glucose transporter (Glut 1) in the telencephalon of the mouse: correlation to the tightening of the blood-brain barrier. , 1995, Brain research. Developmental brain research.

[16]  K. Hirschi,et al.  Diverse roles of the vasculature within the neural stem cell niche. , 2009, Regenerative medicine.

[17]  H. Dvorak,et al.  VEGF‐A Angiogenesis Induces a Stable Neovasculature in Adult Murine Brain , 2004, Journal of neuropathology and experimental neurology.

[18]  R. Stan,et al.  PV1 is a key structural component for the formation of the stomatal and fenestral diaphragms. , 2004, Molecular biology of the cell.

[19]  S. Siehler Cell‐based assays in GPCR drug discovery , 2008, Biotechnology journal.

[20]  Jiaquan Xu,et al.  Deaths: preliminary data for 2011. , 2012 .

[21]  M. Tarnawski,et al.  Increased blood–brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor , 1998, Journal of neurocytology.

[22]  G. Palade,et al.  PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Zlokovic The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.

[24]  W. Schaper,et al.  Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. , 1999, American journal of physiology. Cell physiology.

[25]  D. Shima,et al.  An in vitro assay reveals a role for the diaphragm protein PV-1 in endothelial fenestra morphogenesis , 2006, Proceedings of the National Academy of Sciences.

[26]  Y. Karamanos,et al.  Understanding the blood–brain barrier using gene and protein expression profiling technologies , 2009, Brain Research Reviews.

[27]  K. Alitalo,et al.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.

[28]  Hua Su,et al.  Essential Regulation of CNS Angiogenesis by the Orphan G Protein–Coupled Receptor GPR124 , 2010, Science.

[29]  E. Manseau,et al.  Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. , 2001, The American journal of pathology.

[30]  A. Rojiani,et al.  Glomeruloid vascular structures in glioblastoma multiforme: an immunohistochemical and ultrastructural study. , 1996, Journal of neurosurgery.

[31]  W. Pardridge,et al.  Blood-brain barrier delivery. , 2007, Drug discovery today.

[32]  H. Ohtani Glomeruloid Structures as Vascular Reaction in Human Gastrointestinal Carcinoma , 1992, Japanese journal of cancer research : Gann.

[33]  Andrew P. McMahon,et al.  Canonical Wnt Signaling Regulates Organ-Specific Assembly and Differentiation of CNS Vasculature , 2008, Science.

[34]  Zhiwei Yang,et al.  TGFβ1 and TGFβ3 are partially redundant effectors in brain vascular morphogenesis , 2008, Mechanisms of Development.

[35]  W. Pardridge,et al.  Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. , 1990, The Journal of biological chemistry.

[36]  Holger Gerhardt,et al.  Neuropilin‐1 is required for endothelial tip cell guidance in the developing central nervous system , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[37]  M. Essler,et al.  Proteolytically Processed Soluble Tumor Endothelial Marker (TEM) 5 Mediates Endothelial Cell Survival during Angiogenesis by Linking Integrin αvβ3 to Glycosaminoglycans* , 2006, Journal of Biological Chemistry.

[38]  L. Reichardt,et al.  beta8 integrins are required for vascular morphogenesis in mouse embryos. , 2002, Development.